The authors use a recently completed multidonor hospital study that involved treating donors with albuterol prior to organ recovery as an example of a recent low-risk trial to demonstrate the ongoing need for and challenges involving donor intervention trials. See article by Ware et al on page 621.
No takes yet. Share an insight, caveat, or question.
Gerber et al. (2014) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: